ArticlePloS one2022
Deep learning kidney segmentation with very limited training data using a cascaded convolution neural network.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Deep learning in renal ultrasound: applications, challenges, and future outlook.Frontiers in oncology · 2025Review
- Segmentation of Substantia Nigra in Brain Parenchyma Sonographic Images Using Deep Learning.Journal of imaging · 2023Article
- The utility of automatic segmentation of kidney MRI in chronic kidney disease using a 3D convolutional neural network.Scientific reports · 2023Article
- [A meta-learning based method for segmentation of few-shot magnetic resonance images].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundDeep learning segmentation requires large datasets with ground truth. Image annotation is time consuming and leads to shortages of ground truth data for clinical imaging. This study is to investigate the feasibility of kidney segmentation using deep learning convolution neural network (CNN) models trained with MR images from only a few subjects.
methodsA total of 60 subjects from two cohorts were included in this study. The first cohort of 20 subjects from publicly available data was used for training and testing. The second cohort of 40 subjects with renal masses from our institution was used for testing only. A few-shot deep learning approach using 3D augmentation was investigated. T1-weighted images in the first cohort were used for training and testing. Cascaded CNN networks were trained using images from one, three, and six subjects, respectively. Images for the remaining subjects were used for testing. Images in the second cohort were utilized for testing only. Dice and Jaccard coefficients were generated to evaluate the performance of CNN models. Statistical analyses for segmentation metrics among different approaches were performed.
resultsOur approach achieved mean Dice coefficients of 0.85 using a single training subject and 0.91 with six training subjects. Compared to a single Unet, the cascaded network significantly improved the results using a single training subject (Dice, 0.759 vs. 0.835; p<0.001) and three subjects (0.864 vs. 0.893; p = 0.015) in the first cohort, and the results for the second cohort (0.821 vs. 0.873; p = 0.008).
conclusionOur few-shot kidney segmentation approach using 3D augmentation achieved a good performance even using a single Unet. Furthermore, the cascaded network significantly improved the performance of segmentation and was superior to a single Unet in certain cases. Our approach provides a promising solution to segmentation in medical imaging when the number of ground truth masks is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.